Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001063606 | SCV001228461 | pathogenic | not provided | 2023-07-17 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with HPS3-related conditions. ClinVar contains an entry for this variant (Variation ID: 857848). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Ser462*) in the HPS3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPS3 are known to be pathogenic (PMID: 11590544). |
Baylor Genetics | RCV003467820 | SCV004192309 | likely pathogenic | Hermansky-Pudlak syndrome 3 | 2024-02-20 | criteria provided, single submitter | clinical testing |